In fact, the most prominent disparity observed between the risks observed in carriers with diverse ethnic backgrounds and those identified in individuals of Ashkenazi Jewish descent pertains to the heightened ovarian cancer risk associated with BRCA2 pathogenic variants in AJ populations. The gene discussed is BRCA2; the disease is ovarian cancer.